Search Results - Gillian Morgan Sanchez

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Recapturing disease response: A phase 2 study of carfilzomib 56mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27mg/m2

    Recapturing disease response: A phase 2 study of carfilzomib 56mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27mg/m2 by Barley, Kevin, Sanchez, Larysa, Cho, Hearn J, Parekh, Samir, Madduri, Deepu, Richter, Joshua, Isola, Luis, Goldstein, Talia, Dhadwal, Amishi, Zarychta, Katarzyna, Gillian Morgan Sanchez, Catamero, Donna, Verina, Daniel, Florendo, Erika, Moon‐hee Yum, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Chari, Ajai

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m2

    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m2 by Barley, Kevin, Sanchez, Larysa, Cho, Hearn J., Parekh, Samir, Madduri, Deepu, Richter, Joshua, Isola, Luis, Goldstein, Talia, Dhadwal, Amishi, Zarychta, Katarzyna, Sanchez, Gillian Morgan, Catamero, Donna, Verina, Daniel, Florendo, Erika, Yum, Moon‐hee, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Chari, Ajai

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m 2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m 2

    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m 2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m 2 by Barley, Kevin, Sanchez, Larysa, Cho, Hearn J, Parekh, Samir, Madduri, Deepu, Richter, Joshua, Isola, Luis, Goldstein, Talia, Dhadwal, Amishi, Zarychta, Katarzyna, Sanchez, Gillian Morgan, Catamero, Donna, Verina, Daniel, Florendo, Erika, Yum, Moon-Hee, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Chari, Ajai

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects

    Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects by Johnson, Ben, Lowe, Gillian C, Futterer, Jane, Lordkipanidzé, Marie, MacDonald, David, Simpson, Michael A, Sanchez-Guiú, Isabel, Drake, Sian, Bem, Danai, Leo, Vincenzo, Fletcher, Sarah J, Dawood, Ban, Rivera, José, Allsup, David, Biss, Tina, Bolton-Maggs, Paula Hb, Collins, Peter, Curry, Nicola, Grimley, Charlotte, James, Beki, Makris, Mike, Motwani, Jayashree, Pavord, Sue, Talks, Katherine, Thachil, Jecko, Wilde, Jonathan, Williams, Mike, Harrison, Paul, Gissen, Paul, Mundell, Stuart, Mumford, Andrew, Daly, Martina E, Watson, Steve P, Morgan, Neil V

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects

    SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects by Fletcher, Sarah J, Johnson, Ben, Lowe, Gillian C, Bem, Danai, Drake, Sian, Lordkipanidzé, Marie, Guiú, Isabel Sánchez, Dawood, Ban, Rivera, José, Simpson, Michael A, Daly, Martina E, Motwani, Jayashree, Collins, Peter W, Watson, Steve P, Morgan, Neil V

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: